Edgestream Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Edgestream Partners’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.4M	Sell
2025 Q1	$2.64M	Sell
2024 Q4	$4.85M	Buy
2024 Q3	$3.37M	Buy
2024 Q2	$1.48M	Buy
2024 Q1	$1.14M	Buy
2023 Q4	$1.19M	Buy
2023 Q3	$202K	Sell
2023 Q2	$2.02M	Buy